相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HCC surveillance after SVR in patients with F3/F4 fibrosis
George N. Ioannou
JOURNAL OF HEPATOLOGY (2021)
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease
Valentina Peta et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2020)
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status
Etienne Audureau et al.
JOURNAL OF HEPATOLOGY (2020)
Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
Qiushi Chen et al.
JAMA NETWORK OPEN (2020)
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review
Amit G. Singal et al.
GASTROENTEROLOGY (2019)
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat et al.
LANCET (2019)
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
Fasiha Kanwal et al.
GASTROENTEROLOGY (2019)
Evaluation of a Multifaceted Intervention to Reduce Health Disparities in Hepatitis C Screening: A Pre-Post Analysis
Mamta K. Jain et al.
HEPATOLOGY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis
Thierry Poynard et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Charlotte E. Costentin et al.
GASTROENTEROLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B
M. Houot et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Sample size considerations for the external validation of a multivariable prognostic model: a resampling study
Gary S. Collins et al.
STATISTICS IN MEDICINE (2016)
Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study
Xiaojuan Mi et al.
STATISTICS IN MEDICINE (2016)
Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity
Thierry Poynard et al.
BMJ OPEN (2015)
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C
Thierry Poynard et al.
JOURNAL OF HEPATOLOGY (2013)
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population
Thierry Poynard et al.
JOURNAL OF HEPATOLOGY (2012)
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
Thierry Poynard et al.
BMC GASTROENTEROLOGY (2011)
Hepatocellular Carcinomas in Patients With Metabolic Syndrome Often Develop Without Significant Liver Fibrosis: A Pathological Analysis
Valerie Paradis et al.
HEPATOLOGY (2009)
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
F Imbert-Bismut et al.
LANCET (2001)
分享论文
